Description
Here are some of the specific uses of Azithromycin 250mg (Azuma):
- Respiratory tract infections
- Skin and soft tissue infections
- Sexually transmitted infections
- Ear infections
- Gastrointestinal infections
Sh3,500.00
Azithromycin 250mg (sold under the brand name Azuma) is an antibiotic medication used to treat bacterial infections in different parts of the body.
Here are some of the specific uses of Azithromycin 250mg (Azuma):
Settings | AZITHROMYCIN 250MG AZUMA remove | AMBRODIL SYRP 100ml remove | AMBROX SYRUP 100ml remove | AMBROSAN SYRUP AMBROXOL 100ML remove | Abitol Tablets remove | Artequick Tablets remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh3,500.00 | Sh2,500.00 | Sh3,000.00 | Sh3,000.00 | Sh5,000.00 | Sh11,000.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | Azithromycin 250mg (sold under the brand name Azuma) is an antibiotic medication used to treat bacterial infections in different parts of the body. | Ambroxol syrup is a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. |
| |||
Content |
Here are some of the specific uses of Azithromycin 250mg (Azuma):
| Used for treating
| The main uses of Ambroxol syrup include:
| Prescribed for various respiratory diseases such as
| Abitol Tablet belongs to a group of medicines called antihistamines. It is used in the treatment of various allergic conditions. It relieves symptoms of inflammation as well as itching, swelling and rashes. It is also used to treat loss of appetite (need for food). It is an effective hunger stimulant. | Artequick Tablet Is Used For The Treatment, Control, Prevention, & Improvement Of Malaria And; Acute Liver Injury |
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.